Hims & Hers Health, Inc. (HIMS) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look ...

Hims & Hers is quietly building a healthcare platform, aiming to control the primary interface for diagnostics, prevention, and personalized treatments. Learn more.

Shares of telehealth company Hims & Hers Health (NYSE:HIMS) fell 2.2% in the morning session after Morgan Stanley reiterated ...

Hims & Hers Health shows 50% revenue growth, $1B in cash, and 2.4x 2026 sales with strong personalization and GLP-1 sales.

What the recent share performance signals for Hims & Hers Health (HIMS) Hims & Hers Health (HIMS) has drawn investor ...

Fintel reports that on January 12, 2026, Evercore ISI Group initiated coverage of Hims & Hers Health (NYSE:HIMS) with a In-Line recommendation. Analyst Price Forecast Suggests 46.41% Upside As of ...

In Q3 2025, Hims & Hers Health reported revenue of around US$600 million, nearly 50% year-over-year growth, alongside higher ARPU and free cash flow of US$79 million, even as gross margins faced ...

In the closing of the recent trading day, Hims & Hers Health, Inc. (HIMS) stood at $28.89, denoting a -5.19% move from the ...

Financial giants have made a conspicuous bullish move on Hims & Hers Health. Our analysis of options history for Hims & Hers Health (NYSE:HIMS) revealed 13 unusual trades. Delving into the details, we ...

Virtual healthcare platforms are redefining patient access to care, with Hims & Hers Health, Inc. HIMS and GoodRx Holdings, Inc. GDRX among the leaders in this digital shift. HIMS is a consumer-first, ...